Posted Oct. 26, 2011 at 11:23 a.m.

Premium Lock Biogen reports progress on multiple sclerosis drug

Published: 2011-10-26 11:23:36
Updated: 2011-10-26 11:23:36

Biogen Biogen

In a two-year study, a twice daily dosage reduced the annualized relapse rate for MS patients by 44 percent compared to placebo. At three times a day dosage, relapse rates were reduced by 51 percent....

Read More
Read More

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners


Vivek Wadhwa
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy